0001209191-20-011567.txt : 20200221 0001209191-20-011567.hdr.sgml : 20200221 20200221164347 ACCESSION NUMBER: 0001209191-20-011567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200220 FILED AS OF DATE: 20200221 DATE AS OF CHANGE: 20200221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mamluk Roni CENTRAL INDEX KEY: 0001647053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37500 FILM NUMBER: 20640691 MAIL ADDRESS: STREET 1: CHIASMA, INC. STREET 2: 60WELLS AVENUE CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIASMA, INC CENTRAL INDEX KEY: 0001339469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 460 TOTTEN POND ROAD STREET 2: SUITE 530 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-928-5300 MAIL ADDRESS: STREET 1: 460 TOTTEN POND ROAD STREET 2: SUITE 530 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: CHIASMA INC DATE OF NAME CHANGE: 20050922 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-20 0 0001339469 CHIASMA, INC CHMA 0001647053 Mamluk Roni C/O CHIASMA, INC. 140 KENDRICK STREET, BUILDING C EAST NEEDHAM MA 02494 1 0 0 0 Common Stock 2020-02-20 4 M 0 82186 0.09 A 82186 D Common Stock 2020-02-20 4 S 0 82186 4.54 D 0 D Stock Option (Right to Buy) 3.00 2019-12-20 4 M 0 82186 0.00 D 2022-09-12 Common Stock 82186 0 D The sale was effected pursuant to a Rule 10b5-1 trading plan dated May 17, 2019 adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.45 to $4.60, inclusive. The reporting person undertakes to provide to Chiasma, Inc., any security holder of Chiasma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This option is fully vested and exercisable. /s/ Mark J. Fitzpatrick, Attorney-in-Fact 2020-02-21